Nanoparticles Treat Muscular Dystrophy in Mice (IMAGE)

WashU Medicine

Nanoparticles Treat Muscular Dystrophy in Mice

Caption

Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste. The study's first author, Kristin P. Bibee, M.D., Ph.D., holds vials of nanoparticle formulations.

Credit

Robert Boston

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.